Immunome director Isaac Barchas reports disposal of common shares worth $2.18 million
PUBT · 1d ago
Share
Listen to the news
- Immunome director Isaac Barchas reported selling 83,464 common shares across Aug. 10-12, 2026.
- Sales included 72,416 shares held indirectly, sold at weighted average prices of USD 26.07 and USD 26.23.
- Barchas also sold 11,048 shares directly at USD 27.25.
- Directly held stake rose to 92,211 shares following the Aug. 12 sale.
- Indirect holdings fell to zero following the Aug. 11 sale.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001808343-26-000010), on August 12, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending